Vident Investment Advisory’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-263,492
Closed -$2.62M 1219
2021
Q2
$2.62M Buy
263,492
+411
+0.2% +$3.48K 0.08% 292
2021
Q1
$1.88M Buy
+263,081
New +$1.85M 0.06% 403
2020
Q3
Sell
-187,222
Closed -$650K 919
2020
Q2
$650K Sell
187,222
-30,123
-14% -$104K 0.03% 585
2020
Q1
$511K Sell
217,345
-6,712
-3% -$43.4K 0.03% 574
2019
Q4
$2.35M Buy
+224,057
New +$2.03M 0.15% 208
2017
Q1
Sell
-121,122
Closed -$3.26M 478
2016
Q4
$3.26M Buy
121,122
+7,760
+7% +$192K 0.4% 48
2016
Q3
$2.54M Buy
+113,362
New +$2.28M 0.34% 82
2015
Q4
Sell
-26,519
Closed -$348K 734
2015
Q3
$348K Buy
26,519
+2,900
+12% +$46K 0.05% 661
2015
Q2
$444K Buy
23,619
+1,301
+6% +$27K 0.06% 574
2015
Q1
$419K Buy
22,318
+2,864
+15% +$49.1K 0.08% 520
2014
Q4
$323K Buy
+19,454
New +$410K 0.11% 439

Other funds holding PTEN

Vident Investment Advisory's PTEN Position: Q3 2021 in Review

Vident Investment Advisory sold out of Patterson-UTI (PTEN) in Q3 2021, closing a stake of 263,492 shares — an estimated $2.62M sold.

Vident Investment Advisory first reported a position in PTEN in Q4 2014 and held it in 11 quarters. The position peaked at $3.26M in Q4 2016. 215 funds tracked by Wall St. Rank hold PTEN as of Q3 2021.

  • Vident Investment Advisory reported no remaining Patterson-UTI position as of Q3 2021 after selling out during the quarter.
  • Vident Investment Advisory sold 263,492 Patterson-UTI shares in Q3 2021, an estimated $2.62M.
  • Vident Investment Advisory first reported a position in Patterson-UTI in Q4 2014 and held it in 11 quarters.
  • Vident Investment Advisory's Patterson-UTI position peaked at $3.26M in Q4 2016.
  • 215 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2021.

Based on Vident Investment Advisory's 13F filing for Q3 2021, filed 12 Nov 2021.